Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts. (26th November 2020)

• Record Type: Journal Article
• Authors: Soamalala, Jessica; Diot, Sebastien; Pellerano, Morgan; Blanquart, Christophe; Galibert, Mathieu; Jullian, Magali; Puget, Karine; Morris, May C.
• Is Part Of: Chembiochem. Volume 22:Number 6(2021)
• Page Start: 1065
• Page End: 1071
• Publication Date: 2020-11-26
• Subjects: CDK4 -- CDK6 -- fluorescent biosensors -- kinases -- lung cancer -- mesothelioma -- peptides; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Pharmaceutical chemistry -- Periodicals; 572
• DOI: 10.1002/cbic.202000677
• Languages: English
• ISSNs: 1439-4227

Abstract

Abstract: CDK6 kinase regulates cell‐cycle progression in G1, together with CDK4, but has cell‐, tissue‐ and developmentally distinct functions associated with transcription, angiogenesis and metabolism. Although CDK6 makes an attractive cancer biomarker and target, there are no means of assessing its activity in a complex environment. In this study, we describe the design, engineering and characterisation of a fluorescent peptide biosensor derived from 6‐phosphofructokinase that reports on CDK6 kinase activity through sensitive changes in fluorescence intensity. This biosensor can report on CDK6 activity in a dose‐dependent fashion, thereby enabling quantification of differences in kinase activity in complex and physiologically relevant environments. Further implementation of this biosensor in different lung and melanoma cell lines, as well as in mesothelioma cell lines derived from patients together with a CDK4 biosensor highlighted differences in kinase activity between CDK6 and CDK4 kinase. This work demonstrates the utility of these selective tools for monitoring two closely related kinases comparatively and simultaneously in the same samples, thereby offering attractive perspectives for diagnostic and therapeutic purposes. Abstract : Distinguished kinases : We describe the design, engineering and characterisation of a fluorescent peptide biosensor derived from 6‐phosphofructokinase, that reports on CDK6 kinase activity in vitro and in lung cancer cell extracts. Implementation of this biosensor in mesothelioma cell lines derived from patients highlights differences between CDK6 kinase activity and closely related CDK4 kinase activity.